Evidence map›Paper›PMID 26295349›Full record

ArticlePloS one2015

Genetic Identification Is Critical for the Diagnosis of Parkinsonism: A Chinese Pedigree with Early Onset of Parkinsonism.

Yang Yang, Bei-sha Tang, Ling Weng, Nan Li, Lu Shen, Jian Wang, Chuan-tao Zuo, Xin-xiang Yan, Kun Xia, Ji-feng Guo

2 registry-linked trialsOpen access · goldAbstract read
In one paragraph

Article in PloS one, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 2 registered trials, which are not on this map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
0.9field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT03508960 recruitingnot on this mapstarted 2017, after this paper: background citation

The Chinese Early-onset Parkinson's Disease Registry

TypeobservationalSponsorXiangya Hospital of Central South UniversityRan2017 to 2027Enrolled3,000ConditionsParkinson Disease
NCT03508986 recruitingnot on this mapstarted 2017, after this paper: background citation

The Chinese Familial Parkinson's Disease Registry

TypeobservationalSponsorXiangya Hospital of Central South UniversityRan2017 to 2027Enrolled1,500ConditionsParkinson Disease
3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 11 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. The role ofNeuropsychiatric disease and treatment · 2018
    Article
  7. Article
  8. Recent Advances in Biomarkers for Parkinson's Disease.Frontiers in aging neuroscience · 2018
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 5 institutions in 1 country.

Yang YangDepartment of Neurology, Xiangya Hospital, Central South University, Changsha, 410008, Hunan, People's Republic of China.
Bei-sha TangDepartment of Neurology, Xiangya Hospital, Central South University, Changsha, 410008, Hunan, People's Republic of China; State Key Laboratory of Medical Genetics, Changsha, 410078, Hunan, People's Republic of China; Key Laboratory of Hunan Province in Neurodegenerative Disorders, Central South University, Changsha, 410008, Hunan, People's Republic of China; Neurodegenerative Disorders Research Center, Central South University, Changsha, 410008, Hunan, People's Republic of China.
Ling WengDepartment of Neurology, Xiangya Hospital, Central South University, Changsha, 410008, Hunan, People's Republic of China.
Nan LiDepartment of Neurology, Xiangya Hospital, Central South University, Changsha, 410008, Hunan, People's Republic of China; Key Laboratory of Hunan Province in Neurodegenerative Disorders, Central South University, Changsha, 410008, Hunan, People's Republic of China; Neurodegenerative Disorders Research Center, Central South University, Changsha, 410008, Hunan, People's Republic of China.
Lu ShenDepartment of Neurology, Xiangya Hospital, Central South University, Changsha, 410008, Hunan, People's Republic of China; State Key Laboratory of Medical Genetics, Changsha, 410078, Hunan, People's Republic of China; Key Laboratory of Hunan Province in Neurodegenerative Disorders, Central South University, Changsha, 410008, Hunan, People's Republic of China; Neurodegenerative Disorders Research Center, Central South University, Changsha, 410008, Hunan, People's Republic of China.
Jian WangDepartment of Neurology, Huashan Hospital, Fudan University, 12 Wulumuqi Middle Road, 200040, Shanghai, People's Republic of China.
Chuan-tao ZuoPET Center, Huashan Hospital, Fudan University, 12 Wulumuqi Middle Road, 200040, Shanghai, People's Republic of China.
Xin-xiang YanDepartment of Neurology, Xiangya Hospital, Central South University, Changsha, 410008, Hunan, People's Republic of China; Key Laboratory of Hunan Province in Neurodegenerative Disorders, Central South University, Changsha, 410008, Hunan, People's Republic of China; Neurodegenerative Disorders Research Center, Central South University, Changsha, 410008, Hunan, People's Republic of China.
Kun XiaState Key Laboratory of Medical Genetics, Changsha, 410078, Hunan, People's Republic of China.
Ji-feng GuoDepartment of Neurology, Xiangya Hospital, Central South University, Changsha, 410008, Hunan, People's Republic of China; State Key Laboratory of Medical Genetics, Changsha, 410078, Hunan, People's Republic of China; Key Laboratory of Hunan Province in Neurodegenerative Disorders, Central South University, Changsha, 410008, Hunan, People's Republic of China; Neurodegenerative Disorders Research Center, Central South University, Changsha, 410008, Hunan, People's Republic of China.
Xiangya Hospital Central South University · CNChangsha Medical University · CNCentral South University · CNFudan University · CNHuashan Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundA number of hereditary neurological diseases display indistinguishable features at the early disease stage. Parkinsonian symptoms can be found in numerous diseases, making it difficult to get a definitive early diagnosis of primary causes for patients with onset of parkinsonism. The accurate and early diagnosis of the causes of parkinsonian patients is important for effective treatments of these patients.

methodsWe have identified a Chinese family (82 family members over four generations with 21 affected individuals) that manifested the characterized symptoms of parkinsonism and was initially diagnosed as Parkinson's disease. We followed up with the family for two years, during which we carried out clinical observations, Positron Emission Tomography-Computed Tomography neuroimaging analysis, and exome sequencing to correctly diagnose the case.

resultsDuring the two-year follow-up period, we performed comprehensive medical history collection, physical examination, and structural and functional neuroimaging studies of this Chinese family. We found that the patient exhibited progressive deteriorated parkinsonism with Parkinson disease-like neuropathology and also had a good response to the initial levodopa treatment. However, exome sequencing identified a missense mutation, N279K, in exon 10 of MAPT gene, verifying that the early parkinsonian symptoms in this family are caused by the genetic mutation for hereditary frontotemporal lobar dementia.

conclusionsFor the inherited parkinsonian patients who even show the neuropathology similar to that in Parkinson's disease and have initial response to levodopa treatment, genetic identification of the molecular basis for the disease is still required for defining the early diagnosis and correct treatment.

Indexed as

AdultAge of OnsetAsian PeopleBrainExomeFemaleHumansMagnetic Resonance ImagingMaleMutation, MissenseNeuroimagingParkinsonian DisordersPedigreePositron-Emission Tomographytau ProteinsMAPT protein, humantau Proteins

Identifiers

PMID26295349
PMCPMC4546630
OpenAlexW1809380679

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.